TEVA - Teva Pharma Industries Ltd ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TEVA is currently covered by 8 analysts with an average price target of $20.28. This is a potential upside of $4.27 (26.67%) from yesterday's end of day stock price of $16.01.

Teva Pharma Industries Ltd ADR's activity chart (see below) currently has 333 price targets and 294 ratings on display. The stock rating distribution of TEVA is 81.82% BUY, 15.15% HOLD and 3.03% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.16% with an average time for these price targets to be met of 308.83 days.

Highest price target for TEVA is $30, Lowest price target is $22, average price target is $22.57.

Most recent stock forecast was given by ASHWANI VERMA from UBS on 26-Jun-2025.

Split History since 2000:

7/1/04 2 for 1

12/6/02 2 for 1

2/23/00 2 for 1

Currently out of the existing stock ratings of TEVA, 27 are a BUY (81.82%), 5 are a HOLD (15.15%), 1 are a SELL (3.03%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$23

$6.6 (40.24%)

$30

20 days ago
(26-Jun-2025)

5/9 (55.56%)

$6.44 (38.89%)

69

Hold

$23

$6.6 (40.24%)

$18

2 months 4 days ago
(12-May-2025)

4/8 (50%)

$5.04 (28.06%)

181

Buy

$22

$5.6 (34.15%)

$20

2 months 8 days ago
(08-May-2025)

10/15 (66.67%)

$3.93 (21.75%)

148

Buy

$26

$9.6 (58.54%)

$28

5 months 16 days ago
(30-Jan-2025)

10/13 (76.92%)

$8.16 (45.74%)

335

Buy

$30

$13.6 (82.93%)

$20

5 months 29 days ago
(17-Jan-2025)

11/16 (68.75%)

$8.08 (36.86%)

152

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TEVA (Teva Pharma Industries Ltd ADR) average time for price targets to be met?

On average it took 308.83 days on average for the stock forecasts to be realized with a an average price target met ratio 60.16

Which analyst has the current highest performing score on TEVA (Teva Pharma Industries Ltd ADR) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on TEVA (Teva Pharma Industries Ltd ADR)?

Sumant Kulkarni works at CANACCORD and has 9 price targets and 9 ratings on TEVA

Which analyst is the currently most bullish on TEVA (Teva Pharma Industries Ltd ADR)?

Sumant Kulkarni with highest potential upside - $33.88

Which analyst is the currently most reserved on TEVA (Teva Pharma Industries Ltd ADR)?

David Risinger with lowest potential downside - -$7.4

Teva Pharma Industries Ltd ADR in the News

Teva’s Ajovy Shows Sustained Long-Term Efficacy in Migraine Prevention Trial

Teva Pharmaceutical (NYSE:TEVA) is one of the most undervalued large cap stocks to buy according to analysts. On June 24, Teva Pharmaceutical announced the final analysis results from its PEARL Phase IV migraine prevention trial for Ajovy (fremanezumab), which is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody. The study included individuals with both chronic and...

Teva Recognized Among TIME and Statista's 2025 World's Most Sustainable Companies

The recognition places Teva among the top 500 companies globally making significant progress on Sustainability performance NORTHAMPTON, MA / ACCESS Newswire / July 7, 2025 / Teva is proud to be included in the 2025 TIME and Statista list of the World’s Most Sustainable Companies, a recognition that underscores our commitment to building a healthier,...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?